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Abstract Background: Asthma may be de¢ned either as wheeze within the previous 12 months (current wheeze),
doctor-diagnosed asthma (DDA), or current wheeze plus con¢rmed airway hyperresponsiveness (AHR). Aims: We
wanted to estimate asthmaprevalence inrandomly selected adolescentsbasedondi¡erentcriteria for asthmadiagnosis,
studygenderdi¡erences in reported asthma-like symptoms vsDDA, and relate our ¢ndings tomeasurements of AHR,
levels of exhaled nitric oxide (ENO) and total IgE.Methods: As part of the health survey of North-Trndelag (HUNT),
8571 adolescents aged 13^19 years were investigated with an interview on allergic and respiratory symptoms (phase I
study).Ofthese,401subjectswho reportedwheezewithin the previous12 months (current wheeze) and 213 non-symp-
tomaticcontrolswererandomlyselectedandinvestigatedwith allergyscreening,methacholinebronchoprovocationtest
andmeasurements of ENO (phase II study).Results: In the phase I study, prevalence of current wheezewas 26% (30% in
girls and 23% inboys,Po 0.01).PrevalenceofDDAwas10.8% (10.5% ingirls and11% inboys).Amongsubjectswithcurrent
wheeze, the likelihood of having DDAwasreduced in girls compared to boys, odds ratio (95% CI) 0.82 (0.68-0.98) which
waspartlyexplained by a longerhistoryof wheeze amongboys.In the phase II study, althoughmore girls than boyswith
current wheeze had AHR (62% versus 50%, Po 0.02), more boys than girls reported DDA (44% vs. 32%, Po 0.02).Of
the objective parameters, increased levels of ENOmost strongly increased the riskof having DDA.Conclusions:When
asthma is defined as DDA, there is a risk of underestimating the prevalence of asthma, especially among girls. r 2002
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In Norway, as in most developed countries, an increase
in the prevalence of asthma-like symptoms and doctor-
diagnosed asthma (DDA) has been demonstrated
both in children and adults (1^3). As asthma may be de-
¢ned either as wheeze within the previous 12 months
(current wheeze), DDA, or current wheeze plus con-
¢rmed airway hyperresponsiveness (AHR) (4,5), any
calculated asthma prevalencewill depend on the prevail-Received17 September 2002, accepted in revised form 27 September
2002.
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Department of Lung Medicine,University Hospital of Trondheim,
N-7006 Trondheim,Norway.Fax: +47 73 86 74 24;
E-mail: anne.h.henriksen@medisin.ntnu.noing de¢nition. While prevalence of DDA will be in£u-
enced by how asthma is de¢ned and explained,
prevalence of AHR is in£uenced by the distribution of
age and sex (6^8).
In the present study, we wanted to estimate asthma
prevalence in adolescents based on three di¡erent
criteria for asthma diagnosis, current wheeze, current
wheeze plus con¢rmed AHR and DDA. Secondly,
we wanted to study the relationship between various
asthma-like symptoms and DDA and analyse possible
gender di¡erences in the association between speci¢c
symptoms and the likelihood of having DDA. Finally,
we wanted to compare girls and boys with current
wheeze with and without DDA with respect to ob-
jective parameters of allergy and airway in£ammation,
such as AHR to methacholine and exhaled nitric
oxide (ENO).
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Subjects
Phase I study (Young-HUNT): As part of the Norwegian
North-Trndelag Health Study (HUNT), all residents of
the North-Trndelag county aged13^19 years (9917 indi-
viduals) were invited to attend theYoung-HUNT Study.
The attendants were investigated with a self-adminis-
tered questionnaire, a structured interview containing
validated questions concerning asthma-like symptoms
and allergy, and a clinical investigation with £ow volume
spirometry (9).
Phase II study: According to their answers given during
the interview, three symptomgroups were de¢ned. Sub-
jects from each groupwere randomly invited for further
investigation with allergy screening, measurements of
ENO and a methacholine bronchoprovocation test,
Group1 (264 subjects): wheeze related to allergen expo-
sure; group 2 (375 subjects): wheeze not related to aller-
gen exposure; group 3 (318 subjects): non-symptomatic
controls. Adolescentswithwheeze (groups1and 2) were
investigated during the non-pollen seasons of 1997 and
1998.Non-symptomatic controls (group 3) were investi-
gated in the period from September1997 to June 1998.
Those who were taking antiasthmatic drugs were asked
not to take inhaled or oral b-2-agonists 12h before the
investigation, and smokers were asked to refrain from
smoking 30min before their appointments. A nurse and
a physician carried out the investigations. Those with
symptoms of lower respiratory tract infection or sinusi-
tiswerenot investigated, but testedon a later occasion if
possible.
All subjects, aswell as theparents of subjects less than
16 years of age, gave written informed consent prior to
participation. The study was approved by the regional
ethical committee inTrondheim, and the Data Board In-
spectorate gave their consent.
Methods
Flow-volume spirometry (MasterScope spirometer, soft-
ware version 4.1, Erich Jaeger), andmethacholine broncho-
provocation test (tidal volume triggered equipment,
Automatic Provocation System APS, Erich Jaeger Gmb-
H˛chberg,Germany)wereperformedas havepreviously
been described in detail (10^12). AHR was de¢ned as a
reduction in FEV1Z20% on a cumulative dose ofmetha-
choline (PD20)r 2 mg.
Measurements of ENO were performed in accordance
with the European Respiratory Society Task Force (13)
with an LR 2000 nitric gas analyser (Logan Research
Ltd., Rochester,U.K.). Subjects were in a seated position
and exhaled from total lung capacity against a resistance
of 5-cm H2O to residual volume. The exhalation and
sampling £ow rates were 250ml/s and 250ml/min, re-spectively. For each subject, mean of two plateau levels
from acceptable ENO curves were registered in parts
per billion (ppb).
Allergy screening was performed with serological test-
ing (Phadiatop CAPTM and RAST, Pharmacia Diagnos-
tics, Lund, Sweden). Speci¢c IgE concentrations were
recorded in a scale from 0 to 5, and a test result equal to
or above twowas regarded as a positive RAST.
Questionnaire: In the phase I study, the adolescents
were interviewed by specially trained nurses.The inter-
view contained questions concerning respiratory and al-
lergic symptoms aswell as asthmamedication (Appendix
A).The questions were either adapted fromThe Interna-
tional Study of Asthma and Allergies in Childhood
(ISAAC) (14), fromThe European Community Respira-
tory Health Survey (ECRHS) (15), or they were created
forTheYoungHunt Study.Therewas a time interval of 6^
24 months (mean 12 months) between the phase I and
thephase II study.The adolescentswere classi¢ed as sub-
jects with current wheeze or subjects with current
wheeze plus DDA in accordance with their answers gi-
ven in the phase I study interview.
Statistical analyses
Statistical analyses of the data were performed by
the 1999 SPSS Inc. Windows 10.0 statistical program
(SPSS Inc. 233 S.Chicago, Il,U.S.A.).Data frommeasure-
ments of dose response ratio to methacholine (DRR),
ENO, and total IgEwere close to log-normal distributed,
thus parametric tests were usedwith log-values, and re-
sults presented as geometric mean. Numeric data were
analysed with Independent-Samples t-tests or Mann^
Whitney U-test when appropriate. Categorical data
were analysed with Chi-square tests. Multivariate ana-
lyses with logistic regression were used to calculate ad-
justed odds ratios for DDA, and to ¢nd the model best
¢t to predictDDA.Missingdatawere excluded from ana-
lyses. A two-sided P-valuer 0.05was regarded as statis-
tically signi¢cant.
RESULTS
Phase I study
Asthma-like symptoms vs. doctordiagnosedasthma
(Table 2)
Of the 9917 individuals invited to the phase I study, 8571
subjects (86%) attended the interview. DDA was re-
ported by 10.8%, and 26% reported wheeze during the
previous 12 months (current wheeze). Less than one-
third of the subjects with current wheeze reported
DDA (Table1).
TABLE 1. Adolescents reportingwheezewithinthe previous12 months (currentwheeze)
All Girls Boys
Subjectswith currentwheeze 2242 1278 964
Mean age (range) 15.6 (12^19) 15.6 (12^19) 15.5 (12^19)
Duration of wheeze45 years (%) 331 (15) 154 (12) 177 (18)***
DDA (%) 683 (31) 366 (29) 317 (33)*
Asthmamed. last12 months (%) 638 (29) 354 (28) 284 (30)
Dailycigarette smokers (%) 337 (17) 228 (18) 145 (15)
*P= 0.03, ***Po 0.001.
TABLE 2. Adjusted odds ratios for DDA in adolescentswith current wheeze; a multivariate analysis including reported asth-
ma-like symptoms, gender, duration of wheeze, and age
Symptom Subjects (%) with
DDAif Yes
Subjects (%) with
DDAif No
Adjusted Odds Ratio
(95%CI) for DDAif Yes
Cough atnight in absence of colds 214 (35) 469 (29) 0.85 (0.7^1.1)
Wheeze ordyspnoea in absence of colds 563 (42) 120 (13) 2.50 (1.9^3.2)
Attacks of dyspnoea at rest 563 (45) 506 (27) 1.04 (0.8^1.4)
Attacks of dyspnoea duringnight 141 (61) 542 (27) 1.88 (1.3^2.7)
Allergy-inducedwheeze 398 (60) 285 (18) 2.72 (2.1^3.5)
Wheeze due to exposure from smoke/irritants 273 (55) 410 (24) 1.53 (1.2^2.0)
Wheeze due to exercise 521 (47) 162 (14) 2.63 (2.1^3.4)
Duration of wheeze45 years 305 (61) 378 (22) 3.81 (3.0^4.9)
Cigarette smokingdaily 91 (24) 592 (32) 0.84 (0.6^1.1)
Age F F 1.00 (0.9^1.1)
Female 366 (29) 317 (33) 0.70 (0.6^0.9)
TABLE 3. Univariate analyses ofgenderdi¡erencesinthe likelihoodof having DDAwhenreporting various asthma-like symp-
toms
Adolescentswith currentwheeze Girls% DDA Boys% DDA Oddsratio for DDAin girls vs. boys
Wheeze and dyspnoea in absence of colds 41 45 0.85 (0.7^1.1)
Allergy-inducedwheeze 57 63 0.78 (0.6^1.1)
Wheeze due to exercise 43 53 0.67 (0.5^0.9)
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There was no gender di¡erence in the prevalence
of DDA, 10.5% among girls vs. 11% among boys. How-
ever, more girls than boys had current wheeze, 30% ver-
sus 23%, P o 0.001. Among subjects with current
wheeze, the likelihood of having DDA was reduced in
girls vs. boys, odds ratio (95% CI) 0.82 (0.68^0.98).
This was a trend in all age groups, but most signi¢cant
among those aged 13^14 years, odds ratio (95% CI) 0.65
(0.47^0.88).
In a multivariate analysis including all asthma-like
symptoms, duration of wheeze, cigarette smoking, ageand sex, the likelihood of having DDA was signi¢cantly
reduced among girls compared to boys (Table 2). Of all
the reported symptoms, allergy-related wheeze
(wheeze when exposed to pollen, pets or house dust),
wheeze in absence of colds and exercise-inducedwheeze
most strongly increased the likelihood of having DDA.
When stratifying for sex, wheeze in absence of colds
and allergy-related wheeze were the symptoms most
strongly associated to DDA in girls and boys, respec-
tively. In an univariate analysis, girls reporting exercise-
induced wheeze were less likely than boys to have DDA
(Table 3).
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Subject characteristics
Of the 957 adolescents invited to the phase II study, 622
participated.Of these,151subjectshadwheezerelated to
allergen exposure, 258 had wheeze not related to aller-
gen exposure, and 213 were non-symptomatic controls.
The attendance rates were 57, 69, and 67%, respectively.
Six hundred and eleven subjects completed methacho-
line bronchoprovocation tests, acceptable measure-
ments of ENO were achieved from 613 subjects, and
609 subjects underwent allergy screening.
Genderdi¡erences in airwayhyperresponsiveness vs.DDA
among subjects with current wheeze
DDAwas reportedby 37% and AHR (de¢ned as aZ20%
fall in FEV1 during methacholine bronchoprovocation
test) was con¢rmed in 58% of the adolescents with cur-
rentwheeze.Moreover, 32%of the subjectswith current
wheeze had neither diagnosed asthma nor con¢rmed
AHR.When de¢ned as DDA, asthma was more preva-
lent in boys compared to girls, 43.9 vs. 32.1% (P = 0.015).
However, when de¢ned as current wheeze plus con-
¢rmed AHR, asthmawasmore prevalent in girls (62.4%)TABLE 5. Adolescentswithcurrentwheeze; the associationbe
allergy vs.DDA
DDA +
Girls Boys
DRR gm (95% CI) 39 (27^57) 35 (22
ENOgm (95% CI) 7.6 (6.4^9.1) 13 (10
IgEgm (95% CI) 77 (51^115) 154 (1
DRR: dose response ratio tomethacholine, %/mg;ENO: exh
*Po 0.02, **Po 0.01, ***Po 0.001when comparing girls and bo
TABLE 4. The likelihood of having DDAin girls vs. boyswith cu
orpositive RAST
With DD
Girls
Currentwheeze 78 (32)
Allergy-relatedwheeze 44 (52)
Con¢rmed AHR 55 (37)
Positive RAST 42 (40)
DDA: doctordiagnosed asthma,AHR: airwayhyperresponsithan in boys (50.3%), P = 0.016.When extrapolating the
percentages of subjects with AHR to the larger phase I
study, the estimated prevalence of current wheeze plus
con¢rmed AHR would be 14.7% (18% in girls and 11% in
boys).
Genderdi¡erences in the association between DDA and
reported symptoms vs. objective parameters of lower
airwayin£ammation and allergy
The likelihood of having DDA in girls compared
to boys was reduced also when adjusting for allergy-
related wheeze or AHR, but not when adjusting for a
positive RAST (Table 4). Moreover, positive RAST
tests were more prevalent among boys compared
to girls, 65 vs. 44%. In a multivariate analysis of adoles-
cents with current wheeze including allergy-related
wheeze, AHR, cigarette smoking and age, the likeli-
hood (95% CI) of having DDA in girls vs. boys was 0.6
(0.4^0.9).
Among subjects with DDA, levels of ENO and total
IgEwerehigher inboys compared to girls (Table 5). How-
ever, among those without DDA, the dose response ra-
tio to methacholine (DRR) was more increased in girls.
Of the three objective parameters, an elevated level oftweenobjectiveparametersof lowerairwayin£ammationand
DDA
Girls Boys
^54) 17 (14^21)** 9.7 (7.3^13)
^16)*** 5.2 (4.8^5.7) 7.1 (6.1^8.2)***
11^214)* 32 (24^41) 47 (31^71)
alednitric oxide; gm: geometricmean.
ys.
rrentwheezewhen adjusting for allergy-relatedwheeze,AHR
A (%) Adjusted Odds Ratios for
DDAin girls vs. boys
Boys
72 (44) 0.60 (0.40^0.91)
41 (62) 0.62 (0.40^0.96)
46 (58) 0.55 (0.35^0.84)
58 (55) 0.71 (0.46^1.09)
veness.
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having DDA in both sexes.
DISCUSSION
In the present study, wheeze within the preceding 12
months (currentwheeze)was reportedby 26%,whereas
10.8% hadDDA.While theprevalence of currentwheeze
was increased in girls compared to boys, there was no
genderdi¡erence in theprevalence ofDDA.Thus, among
adolescentswith currentwheeze the likelihood of having
DDAwas reduced in girls.This gender di¡erence in DDA
could not be explained by di¡erences in reported asth-
ma-like symptoms.
Among adolescentsreporting currentwheezewho at-
tended the phase II study, 58% had con¢rmed AHR,
whereas 37% had DDA. One-third had neither con-
¢rmed AHR nor diagnosed asthma.DDAwas more fre-
quent in boys compared to girls. However, AHR was
more frequent in girls, and the likelihood of having DDA
was reduced in girls irrespective of presence of AHR. In
addition to the duration of wheeze, allergy-related
wheeze, and increased levels of ENO, amarker of airway
in£ammation in atopic asthma [11] were associated with
an increased likelihood of having DDA.Thus, the risk of
under-diagnosing asthma seems higher among subjects
reporting wheeze not related to allergy.
Our primary aim was to estimate asthma prevalence
based on various criteria for asthma diagnosis.The pre-
valence of currentwheeze and DDAwere based on data
from the phase I study, a huge epidemiological survey in-
cluding 85% of all adolescents residing in the North-
Trndelag county. Compared to subjects reporting cur-
rent wheeze in the phase I study, those who also re-
ported current wheeze when attending the phase II
study, would represent a selected group. In order to
avoid any selection bias when interpreting results from
the phase II study, subjects were categorised according
to their answers given in the phase I study interview.
Thus, changes in symptom status and diagnosing of asth-
ma that took place during the 6^24 (mean 12) months
passing between the two studies were not accounted
for. As a consequence, some subjects with current
wheeze who got an asthma diagnosis during this period
were wrongly categorised as subjects with current
wheeze without DDA.However, the yearly incidence of
DDA is relatively low during adolescence(16). Consider-
ing the ¢ndings by Lars Larsson of a1.1% yearly incidence
(1.4% in females and 0.8% inmales) of DDA among Swed-
ish adolescents (17), it is unlikely that such misclassi¢ca-
tion of subjects would change our conclusions.
The 26% prevalence of currentwheezewas high com-
pared to the10.8% prevalence of parental reported occa-
sional wheeze among Norwegian children reported by
Nystad et al. (2). However, there was no striking di¡er-ence in the prevalence of DDAbetween the two studies,
10.8 and 9.3%, respectively.While parents answer most
questionnaires concerning childhood asthma, from the
age of12 an increasingnumber of the subjects themselves
answer the questionnaires (18). Therefore, when com-
paring di¡erences in the prevalence of childhood, adoles-
cent and adult asthma, results may be biased by
variations in the communication between parent and
child and between parents or subjects and doctors. In-
terestingly, our data were in line with the results from a
study of 2693 adolescents living in Midwestern cities,
U.S.A., where current wheeze was reported by 25%
(19).Moreover, according to the ISAAC study, prevalence
of current wheeze among British 12^14 year olds was
33.3% (20). Inboth studies, prevalence of current wheeze
was increased in girls compared to boys. In contrast to
our ¢ndings, in theMidwestern study, the increased pre-
valence of wheeze among girls was also re£ected in an
increased prevalence of ever diagnosed asthma in girls
compared to boys.
In any study, the estimated asthma prevalencewill de-
pend onhow asthma is de¢ned.Questionnaires and tests
used in epidemiological studies havebeen comparedwith
clinically diagnosed asthma (21, 22), but no consensus of a
‘‘gold standard’’ for de¢ning asthma has been reached
(23). In epidemiological studies, the prevalence of re-
portedDDA is oftenused as a parameter of asthma pre-
valence. However, before getting an asthma diagnosis,
symptomsmust be perceived and presented to a doctor
(24) and the doctor must recognise the symptoms as
asthma-like (25). Thus, asthma prevalence may be un-
der-estimated. On the other hand, when using current
wheeze as an indicator for asthma, the result may be an
over-estimated prevalence of asthma. We found that
one-third of those reporting current wheeze did not
have asthma either when de¢ned as DDA or as current
wheeze plus con¢rmed AHR.
In the present study, AHRwas increased in girls com-
pared to boys.The relationship between airway calibre,
lung volume and AHR has been discussed in several pa-
pers (6^8). In the longitudinal study of Paoletti and col-
leagues, AHR was increased in subjects o13 years in
both sexes compared to older age groups (8).With in-
creasing age, reduction in AHR tended to be more pro-
found inmales compared to females, and after childhood
AHR appeared higher in females than inmales unrelated
to airway calibre and lung volume. It has also been shown
that more girls than boys develop asthma during adoles-
cence (26).This is in linewith our ¢ndings of an increased
frequency of con¢rmed AHR in girls in spite of a shorter
history of wheeze compared to boys.One can speculate
whether these girls areunder-diagnosed asthmaticswho
will become diagnosed asthmatics during early adult-
hood.
Some authors have pointed out that only when
female patients behave ‘‘just like a man’’, i.e. presents
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as male patients,Yentl Syndrome (24, 27).The increased
likelihood of having diagnosed asthma in subjectswith al-
lergy-relatedwheezemayre£ect an attitude among doc-
tors that asthma is primarily an atopic disease. When
compared toboys, fewergirlswere atopic and their asth-
ma symptoms were less often related to allergen expo-
sure.Thus, asthmamightmore easilybeunder-diagnosed
in girls.
In summary, among adolescents reporting current
wheeze, one-third had DDA, whereas about 55% had
con¢rmed AHR. When current wheeze or current
wheezeplus con¢rmedAHRwereused as gold standards
for asthma, asthma prevalence was increased in girls
compared to boys. This gender di¡erence was not re-
£ected in DDA, having the same prevalence in both
sexes.Moreover, current wheeze was more strongly as-
sociated to markers of allergy in boys compared to girls
and there was a signi¢cant association between DDA
and allergy-related symptoms as well as markers of al-
lergy.
We conclude that gender di¡erences in asthma preva-
lence depend on what is chosen as prevalence indicator
for asthma.The reduced likelihood of diagnosing asthma
in girls compared to boys was partly explained by a
stronger association between current wheeze and al-
lergy and a longer history of wheeze among boys. How-
ever, some under-diagnosing of asthma due to female
gender could not be excluded.
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APPENDIXA
Keyquestions and alternative answers used
in the study
Questions Possible answers
Have you ever had wheezing
or whistling in the chest at
any time inthe past?a
Yes No
Have you ever had wheezing
or whistling in the chest in the
last12 months?a
Yes No
Haveyoueverhad asthma? Yes NoREFERENCES
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